About the Event

Commercial licensing and University Spin off/Startup are the two most important avenues to commercialise University inventions. However, it is not a trivial task to perform a sound valuation and to understand what may be considered as a fair deal among the investor, founder and University TTO.

The recently published university spin-out investment terms (USIT) by a group of prominent Uni TTOs in the UK and US shines a light on the international practice that could also inspire and influence our practice in Australia.

KCA NSW Network is delighted to have Ms Stephanie Morris (GAICD & CLP), Director of Translation and Innovation Adelaide Intermediary Program as our invited speaker. Ms Morris contributed to the production of USIT and will provide a debrief and insights - an event not to be missed.

Agenda

17:30 - 18:00 Pre-Event Registration

18:00 - 18:30 Presentation by invited speaker

18:30 - 20:00 Event Close

Speaker's Bio:

Stephanie Morris is a life-sciences professional with expertise medical technology commercialisation. Currently she is Director of Innovation and Translation, AIP at MTPConnect delivering activities that strategically build capacity, connection and opportunity and help to drive the growth of health and biomedical innovation and translation.

Stephanie most recently headed the industry partnerships and translational activities for academic discovery and innovation at Imperial College London’s Faculty of Medicine in UK, a world top ten university, where she still is an expert consultant. She facilitated the recently released ‘University Spin-out Investment Terms’ (USIT) Guide for the UK members of TenU, an international collaboration formed to capture effective practices in research commercialisation.

Her expertise extends from having worked within start-up companies and SMEs to large multinational pharmaceutical organisations at operational and governance levels. She brings experience from across the full care continuum, including academia, R&D, clinical development, commercialisation, investment as well as working directly with patients in both acute and chronic settings in the community.

Stephanie holds a MBA from the University of South Australia, is a Graduate of the Australian Institute of Company Directors (GAICD), a Certified Licensing Professional (CLP), and has graduate qualifications in both Business and Biomedical Science. She is also Deputy Chair for Cure4CF Foundation, a not-for-profit organisation driven to find a cure for cystic fibrosis.

Visit the website for more information.

---